• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D受体在胰腺癌细胞中表达,一种维生素D3类似物可减少细胞数量。

Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number.

作者信息

Albrechtsson Elin, Jonsson Tord, Möller Sebastian, Höglund Mattias, Ohlsson Bodil, Axelson Jan

机构信息

Department of Surgery, Lund University, Sweden.

出版信息

Pancreatology. 2003;3(1):41-6. doi: 10.1159/000069149.

DOI:10.1159/000069149
PMID:12649563
Abstract

BACKGROUND AND AIM

The vitamin D-receptor (VDR) has been detected in both normal and malignant cells of different tissues. Treatment with vitamin D(3) has been suggested as a possible therapy in malignant diseases such as pancreatic cancer. Synthetic analogues of vitamin D(3) have a less hypercalcemic effect than native vitamin D(3). The aim was to study the expression of the VDR in human pancreatic cancers and to study the in vitro effect of an analogue to vitamin D(3) on cell lines established from these cancers.

METHODS

The pancreatic cancer cell lines were established from primary cultures with only cancer cells. A probe specific for the human VDR was used. After reverse-transcriptase PCR and Northern blotting, the expression of the VDR in normal pancreas and in pancreatic cancers was compared. The cell lines were incubated with EB 1089, a synthetic analogue vitamin of D(3), in dose-response studies. The cell number was measured by the XTT colorimetric method.

RESULTS

The VDR was expressed in all cancers and in six of the cell lines the expression was increased more than 3-fold compared to normal pancreas. All cell lines developed from human pancreatic cancers responded with a decreased cell number to the vitamin D(3) analogue at concentrations of 10(-5) M or higher.

CONCLUSION

The VDR was expressed in all pancreatic cancers studied. Cell lines derived from these cancers responded with a decrease in cell number to high concentrations of a vitamin D(3) analogue. These results, and the doses to use, have to be confirmed with in vivo studies.

摘要

背景与目的

在不同组织的正常细胞和恶性细胞中均检测到维生素D受体(VDR)。维生素D₃治疗已被提议作为胰腺癌等恶性疾病的一种可能疗法。维生素D₃的合成类似物比天然维生素D₃具有更低的高钙血症效应。本研究旨在探讨VDR在人胰腺癌中的表达情况,并研究一种维生素D₃类似物对源自这些癌症的细胞系的体外作用。

方法

从仅含癌细胞的原代培养物中建立胰腺癌细胞系。使用针对人VDR的特异性探针。经过逆转录聚合酶链反应(RT-PCR)和Northern印迹分析,比较VDR在正常胰腺和胰腺癌中的表达。在剂量反应研究中,将细胞系与维生素D₃的合成类似物EB 1089孵育。通过XTT比色法测量细胞数量。

结果

所有癌症中均检测到VDR表达,在六个细胞系中,与正常胰腺相比,VDR表达增加了3倍以上。源自人胰腺癌的所有细胞系在10⁻⁵M或更高浓度的维生素D₃类似物作用下,细胞数量均减少。

结论

在所研究的所有胰腺癌中均检测到VDR表达。源自这些癌症的细胞系在高浓度维生素D₃类似物作用下细胞数量减少。这些结果以及所用剂量必须通过体内研究加以证实。

相似文献

1
Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number.维生素D受体在胰腺癌细胞中表达,一种维生素D3类似物可减少细胞数量。
Pancreatology. 2003;3(1):41-6. doi: 10.1159/000069149.
2
Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines.维生素A和D可减少人胰腺癌细胞系中的细胞数量,而维生素E和K则不然。
Scand J Gastroenterol. 2004 Sep;39(9):882-5. doi: 10.1080/00365520410006701.
3
Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.维生素D受体过表达提示胆管癌预后良好:对治疗的意义
Cancer. 2007 Jun 15;109(12):2497-505. doi: 10.1002/cncr.22716.
4
1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.1α,25-二羟基维生素D3和全反式维甲酸抑制一种肺癌细胞系的生长。
Anticancer Res. 1996 Sep-Oct;16(5A):2653-9.
5
Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer.维生素D受体表达作为胰腺癌潜在的预后因素和治疗靶点
Histopathology. 2015 Sep;67(3):386-97. doi: 10.1111/his.12663. Epub 2015 Mar 31.
6
A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.对维生素D受体亲和力低的1,25 -(OH)₂D₃的A环类似物通过依赖于细胞成熟的膜效应调节软骨细胞。
J Cell Physiol. 1997 Jun;171(3):357-67. doi: 10.1002/(SICI)1097-4652(199706)171:3<357::AID-JCP14>3.0.CO;2-7.
7
Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
J Surg Res. 1996 Feb 15;61(1):127-33. doi: 10.1006/jsre.1996.0092.
8
Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.维生素D3的活性代谢产物及其类似物EB1089可诱导大肠腺瘤和癌细胞发生凋亡:对预防和治疗的潜在意义。
Cancer Res. 2000 Apr 15;60(8):2304-12.
9
1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.1,25-二羟维生素D3通过间接基因激活和受体稳定上调肾脏维生素D受体。
Arch Biochem Biophys. 2005 Jan 15;433(2):466-73. doi: 10.1016/j.abb.2004.10.001.
10
The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.25-羟基维生素D3和19-去甲-1α,25-二羟基维生素D2作为前列腺癌治疗药物的体外评价
Clin Cancer Res. 2000 Mar;6(3):901-8.

引用本文的文献

1
The therapeutic potential of vitamins A, C, and D in pancreatic cancer.维生素A、C和D在胰腺癌中的治疗潜力。
Heliyon. 2024 Dec 31;11(1):e41598. doi: 10.1016/j.heliyon.2024.e41598. eCollection 2025 Jan 15.
2
Vitamin D and Pancreatic Ductal Adenocarcinoma-A Review of a Complicated Relationship.维生素D与胰腺导管腺癌——复杂关系综述
Nutrients. 2024 Nov 27;16(23):4085. doi: 10.3390/nu16234085.
3
The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies.
循环25-羟维生素D与胰腺癌之间的关联:一项观察性研究的系统评价和荟萃分析
Eur J Nutr. 2024 Apr;63(3):653-672. doi: 10.1007/s00394-023-03302-w. Epub 2024 Jan 3.
4
Prognostic role of vitamin D receptor in digestive system tumours: A systematic review and preliminary meta-analysis.维生素 D 受体在消化系统肿瘤中的预后作用:系统评价和初步荟萃分析。
PLoS One. 2023 Aug 10;18(8):e0289598. doi: 10.1371/journal.pone.0289598. eCollection 2023.
5
Bile Acids and Microbiota Interplay in Pancreatic Cancer.胰腺癌中胆汁酸与微生物群的相互作用
Cancers (Basel). 2023 Jul 11;15(14):3573. doi: 10.3390/cancers15143573.
6
New Roles for Vitamin D Superagonists: From COVID to Cancer.维生素 D 超强激动剂的新作用:从新冠到癌症。
Front Endocrinol (Lausanne). 2021 Mar 31;12:644298. doi: 10.3389/fendo.2021.644298. eCollection 2021.
7
A Narrative Role of Vitamin D and Its Receptor: With Current Evidence on the Gastric Tissues.维生素 D 及其受体的叙述性作用:基于目前对胃组织的证据。
Int J Mol Sci. 2019 Aug 5;20(15):3832. doi: 10.3390/ijms20153832.
8
Associations of serum 25-hydroxyvitamin D with metabolic syndrome and its components in elderly men and women: the Korean Urban Rural Elderly cohort study.血清 25-羟维生素 D 与老年男女代谢综合征及其组分的关系:韩国城乡老年队列研究。
BMC Geriatr. 2019 Apr 11;19(1):102. doi: 10.1186/s12877-019-1118-y.
9
The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer.高剂量维生素D3在胰腺癌中的偶然应用。
Case Rep Pancreat Cancer. 2016 May 1;2(1):32-35. doi: 10.1089/crpc.2016.0003. eCollection 2016.
10
Vitamin D and Gastrointestinal Cancers: A Narrative Review.维生素 D 与胃肠道癌症:一篇叙述性综述。
Dig Dis Sci. 2019 May;64(5):1098-1109. doi: 10.1007/s10620-018-5400-1. Epub 2018 Dec 3.